Loading...
XSHG600252
Market cap1.08bUSD
Jan 14, Last price  
2.36CNY
1D
3.06%
1Q
5.36%
Jan 2017
-48.47%
Name

Guangxi Wuzhou Zhongheng Group Co.

Chart & Performance

D1W1MN
XSHG:600252 chart
P/E
93.90
P/S
2.56
EPS
0.03
Div Yield, %
1.36%
Shrs. gr., 5y
0.12%
Rev. gr., 5y
-1.26%
Revenues
3.10b
+14.10%
475,739,582324,016,775321,168,473285,783,099628,166,157712,395,8881,425,697,3441,150,551,2651,945,718,4533,996,697,6413,214,406,3891,343,085,1451,670,061,9922,047,709,2763,298,765,2833,814,056,0853,676,393,7023,161,843,6462,713,769,8383,096,542,053
Net income
84m
+580.48%
2,094,937019,663,50236,578,76047,007,169125,709,148398,574,986374,929,597683,921,037742,515,8781,594,536,436520,158,884489,356,682604,914,988613,351,971744,951,596236,081,657173,166,28912,389,67484,308,789
CFO
484m
144,055,91956,136,744199,414,43140,754,22259,467,3750191,734,9910906,427,707945,099,660569,946,797291,525,5051,495,621,750893,214,443853,399,912654,312,676656,615,88400484,100,303
Dividend
Jun 24, 20240.01 CNY/sh

Profile

Guangxi Wuzhou Zhongheng Group Co., Ltd. researches, develops, manufactures, and sells pharmaceuticals in China. The company offers pills, capsules, and injections and tablets for cardiovascular and cerebrovascular diseases, bruises, gynecological diseases, and respiratory diseases. It also produces health food products under the DOUBLE MONEY brand, as well as health-care functional beverages, smokable turtle pastes, jelly-type turtle paste, etc. The company is based in Wuzhou, China.
IPO date
Nov 30, 2000
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
3,096,542
14.10%
2,713,770
-14.17%
Cost of revenue
2,816,978
2,429,893
Unusual Expense (Income)
NOPBT
279,564
283,877
NOPBT Margin
9.03%
10.46%
Operating Taxes
52,227
51,417
Tax Rate
18.68%
18.11%
NOPAT
227,337
232,460
Net income
84,309
580.48%
12,390
-92.85%
Dividends
(107,390)
(92,481)
Dividend yield
1.25%
1.03%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
1,028,342
1,314,763
Long-term debt
564,698
666,298
Deferred revenue
170,673
173,084
Other long-term liabilities
73,936
16,100
Net debt
(3,357,623)
(3,293,338)
Cash flow
Cash from operating activities
484,100
CAPEX
(166,925)
Cash from investing activities
(812,051)
253,324
Cash from financing activities
(290,824)
329,032
FCF
6,541
51,860
Balance
Cash
3,590,094
4,200,297
Long term investments
1,360,569
1,074,102
Excess cash
4,795,836
5,138,710
Stockholders' equity
7,499,801
8,378,106
Invested Capital
5,307,403
5,231,796
ROIC
4.31%
4.21%
ROCE
2.75%
2.73%
EV
Common stock shares outstanding
3,427,187
3,425,209
Price
2.51
-4.56%
2.63
-31.87%
Market cap
8,602,238
-4.51%
9,008,299
-31.87%
EV
6,951,980
7,486,634
EBITDA
456,624
473,633
EV/EBITDA
15.22
15.81
Interest
65,525
81,912
Interest/NOPBT
23.44%
28.85%